BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
Close on Nov 12, 2026Market cap $188.41MP/E –Yield –
BridgeBio Oncology Therapeutics statistics
61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 4, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.64
- 2.29
Share statisticsIndustry
- Shares Change (QoQ)
- 0.15%
- 0.48%
- Float
- 42M
- 49M
- Shares Held by Insiders
- 47.1%
- 12.1%
- Shares Held by Institutions
- 73.8%
- 56.4%
Short sellingIndustry
- Short Interest
- 3M
- –
- Short Interest Change
- -9.82%
- -0.76%
- Short % of Float
- 8.18%
- 9.06%
- Short % of Shares Outstanding
- 4.33%
- 6.30%
- Days to Cover
- 5.10
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $14.87
- –
- 52-Week Low
- $1.98
- –
- 20-Day Moving Average
- $2.53
- –
- 50-Day Moving Average
- $3.79
- –
- 200-Day Moving Average
- $7.69
- –
- Average True Range (14)
- $0.29
- –
- Price Change (1 Week)
- 8.29%
- 1.51%
- Price Change (1 Month)
- -19.1%
- -2.37%
- Price Change (3 Months)
- -74.1%
- -21.1%
- Price Change (6 Months)
- -72.4%
- -22.8%
- Price Change (YTD)
- -81.2%
- -22.6%
- Price Change (1 Year)
- -81.6%
- -21.0%
- Average Volume (10 Days)
- 682,405
- –
- Average Volume (20 Days)
- 704,057
- –
- Average Volume (90 Days)
- 519,854
- –
- Relative Volume
- 1.50
- 0.80
- Relative Strength Index (14)
- 36.1
- 44.7
- Volatility (1 Year)
- 74.5%
- 80.2%
- Beta (5 Years)
- 0.54
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -46.4%
- -51.3%
- Return on Assets (ROA)
- -41.3%
- -40.7%
- Return on Capital Employed (ROCE)
- -63.4%
- -38.1%
Financial positionIndustry
- Current Ratio
- 4.08
- 3.31
- Quick Ratio
- 6.18
- 2.41
EfficiencyIndustry
- Profits Per Employee
- -$1.86M
- -$683.67K
- Employee Count
- 92
- 75
- WACC
- 7.60%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $315.30M
- $16.98M
- Net Cash Per Share
- $3.93
- $0.72
- Equity (Book Value)
- $293.39M
- $52.68M
- Book Value Per Share
- $3.66
- $1.50
- Tangible Book Value
- $293.39M
- $26.74M
- Working Capital
- $157.30M
- $78.52M
Cash flow (TTM)Industry
- Capital Expenditures
- -$157.00K
- -$944.00K
- FCF Per Share
- -$1.88
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -91.0%
- -21.0%
- FCF Yield
- -80.2%
- -9.44%
- Buyback Yield
- -55.0%
- -0.73%
- Shareholder Yield
- -55.0%
- 0.00%
Scores and fair valueIndustry
- Altman Z-Score
- -1.08
- 0.26
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BBOT | S&P 500 | Difference | BBOT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -27.9% | -2.7% | −25.2 pts | ||
| 3 months | -75.1% | -1.7% | −73.3 pts | ||
| Year to date | -81.2% | +11.9% | −93.1 pts | ||
| 1 year | -81.4% | +12.0% | −93.4 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
3M BBOT shares were sold short on Oct 30, 2026, down 9.8% from the previous report, or 8.18% of the shares available to trade. At recent volumes it would take 5.1 days to buy them back. Over the last 20 sessions, 29.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,468,496 | -9.8% | 680,248 | 5.1 |
| Oct 15, 2026 | 3,846,319 | +14.0% | 542,651 | 7.1 |
| Sep 30, 2026 | 3,374,885 | -6.1% | 624,657 | 5.4 |
| Sep 15, 2026 | 3,595,979 | -41.9% | 824,822 | 4.4 |
| Aug 31, 2026 | 6,193,538 | +6.6% | 298,249 | 20.8 |
| Aug 14, 2026 | 5,808,214 | -0.3% | 234,207 | 24.8 |
| Jul 31, 2026 | 5,826,298 | +2.4% | 280,563 | 20.8 |
| Jul 15, 2026 | 5,688,384 | +9.1% | 451,434 | 12.6 |
| Jun 30, 2026 | 5,212,731 | +32.3% | 726,372 | 7.2 |
| Jun 15, 2026 | 3,940,239 | +1.9% | 251,629 | 15.7 |
| May 29, 2026 | 3,866,368 | +18.0% | 464,305 | 8.3 |
| May 15, 2026 | 3,275,227 | -1.4% | 323,701 | 10.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?